Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
11584022 Canada Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 2 distinct examiners, while the portfolio is currently active in 1 distinct art unit. WAX, ROBERT A is the busiest examiner, with 1 pending office action.
Although there are 2 distinct examiners involved, the use of 1 distinct art unit suggests the pending matters are technically related. This allows the company to maintain some consistency in its technical arguments even as it interacts with different examiners. WAX, ROBERT A is responsible for the pending office action, representing half of the company's current workload in the Biotechnology & Pharmaceuticals sector.
The distribution of 2 pending office actions among distinct examiners means that the company must navigate separate sets of examiner preferences. However, the art unit provides a unified procedural environment for both cases. Practitioners should focus on the specific feedback from WAX, ROBERT A for the pending office action under their review, while also monitoring the second examiner's actions for potential overlap in the art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WAX, ROBERT A | 1 | 25.0% | +3.9% |
| BABSON, NICOLE PLOURDE | 1 | 46.6% | +33.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258914 | HOMOGENEOUS BIOPOLYMER SUSPENSIONS, PROCESSES FOR MAKING SAME AND USES THEREOF | BABSON, NICOLE PLOURDE | 79d overdue |
| 18879363 | BIOPOLYMER COMPOSITIONS FOR USE IN AGRICULTURE | WAX, ROBERT A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258914 | HOMOGENEOUS BIOPOLYMER SUSPENSIONS, PROCESSES FOR MAKING SAME AND USES THEREOF | BABSON, NICOLE PLOURDE | 79d overdue |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18879363 | BIOPOLYMER COMPOSITIONS FOR USE IN AGRICULTURE | WAX, ROBERT A | — | §102§103DP | Non-Final OA | — | Pending | Dec 27, 2024 |
| 18258914 | HOMOGENEOUS BIOPOLYMER SUSPENSIONS, PROCESSES FOR MAKING SAME AND USES THEREOF | BABSON, NICOLE PLOURDE | 1619 | §102§103§112Other | Final Rejection | 79d overdue | Pending | Jun 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial